Crispr Therapeutics shares owned by Concannon Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Concannon Wealth Management
from 13F filings
Historical chart of Concannon Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Concannon Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Concannon Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-06-30 | $1.0k | 20 | 50.00 |
| 2022-03-31 | $4.0k | 60 | 66.67 |
| 2021-12-31 | $55k | 720 | 76.39 |
| 2021-09-30 | $86k | 765 | 112.42 |
| 2021-06-30 | $124k | 765 | 162.09 |
| 2021-03-31 | $93k | 765 | 121.57 |
More positions owned by Concannon Wealth Management
View all positions for Concannon Wealth Management